N ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial

Lai, Zhi‐Wei, Hanczko, Robert, Bonilla, Eduardo, Caza, Tiffany N., Clair, Brandon, Bartos, Adam, Miklossy, Gabriella, Jimah, John, Doherty, Edward, Tily, Hajra, Francis, Lisa, Garcia, Ricardo, Dawood, Maha, Yu, Jianghong, Ramos, Irene, Coman, Ioana, Faraone, Stephen V., Phillips, Paul E., Perl, Andras·2012·Arthritis & Rheumatism

Cited by (427)

Items 201–300 of 427

  1. Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
    Liyan Lin, Ruyu Ren, Qiao Xiong, Chunfu Zheng, Bin Yang, Huiqing Wang · 2024 · Autoimmunity Reviews
  2. T regulatory cells metabolism: The influence on functional properties and treatment potential
    Martyna Tomaszewicz, Anna Ronowska, Maciej Zieliński, Agnieszka Jankowska-Kulawy, Piotr Trzonkowski · 2023 · Frontiers in Immunology
  3. Perturbation in cellular redox homeostasis: Decisive regulator of T cell mediated immune responses
    Lokesh Gambhir, Vineet Sharma, Pankaj Kandwal, Sanjai Saxena · 2018 · International Immunopharmacology
  4. Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments
    Janika Härm, Yu-Tong Fan, Dirk Brenner · 2024 · Current Opinion in Immunology
  5. Metabolic reprogramming as a therapeutic target for modulating the Th17/Treg balance in autoimmune diseases: a comprehensive review
    Yuehong Hu, Qihan Zhao, Haoran Dai, Yadi Wu, Xinyue Tang, Naiqian Zhang, Hanxue Jiang, Hongliang Rui, Baoli Liu · 2025 · Frontiers in Immunology
  6. Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation
    Aparna Godavarthy, Ryan Kelly, John R. Jimah, Miguel Beckford, Tiffany N. Caza, David Fernández, Nick Huang, Manuel Duarte, Joshua Lewis, Hind J. Fadel et al. · 2019 · JCI Insight
  7. Management of cardiovascular disease in patients with systemic lupus erythematosus
    Paramarajan Piranavan, András Perl · 2020 · Expert Opinion on Pharmacotherapy
  8. The key player in the pathogenesis of environmental influence of systemic lupus erythematosus: Aryl hydrocarbon receptor
    Jingwen Wu, Tianyi Pang, Ziyuan Lin, Ming Zhao, Hui Jin · 2022 · Frontiers in Immunology
  9. Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus
    Marcella Prete, Patrizia Leone, M A Frassanito, Vanessa Desantis, Carolina Marasco, Sebastiano Cicco, Franco Dammacco, Angelo Vacca, Vito Racanelli · 2018 · Lupus
  10. The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis
    Despina Michailidou, Yevgeniya Gartshteyn, Anca Askanase, András Perl · 2025 · Autoimmunity Reviews
  11. Transcriptional and metabolic programs promote the expansion of follicular helper T cells in lupus-prone mice
    Minghao Gong, Seung‐Chul Choi, Yuk Pheel Park, Xueyang Zou, Ahmed Samir Elshikha, Valerie A. Gerriets, Jeffrey C. Rathmell, Mansour Mohamazadeh, Laurence M Morel · 2023 · iScience
  12. The Impact of Protein Acetylation/Deacetylation on Systemic Lupus Erythematosus
    Jingjing Ren, Eric James Panther, Xiaofeng Liao, Amrie C. Grammer, Peter E. Lipsky, Christopher M. Reilly · 2018 · International Journal of Molecular Sciences
  13. The Influence of Diet and Obesity on Gene Expression in SLE
    Antonio La Cava · 2019 · Genes
  14. Systemic Lupus Erythematosus: Pathogenesis at the Functional Limit of Redox Homeostasis
    Jay Pravda · 2019 · Oxidative Medicine and Cellular Longevity
  15. Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice
    Christopher Wilson, Blair T. Stocks, Emilee M. Hoopes, Jillian P. Rhoads, Kelsey L. McNew, Amy Stasny Major, Daniel J. Moore · 2021 · JCI Insight
  16. Effects of N-acetylcysteine supplementation on disease activity, oxidative stress, and inflammatory and metabolic parameters in rheumatoid arthritis patients: a randomized double-blind placebo-controlled trial
    Kamal Esalatmanesh, Alireza Jamali, Roozbeh Esalatmanesh, Zahra Soleimani, Alireza Khabbazi, Aida Malek Mahdavi · 2022 · Amino Acids
  17. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications
    Hong‐Tai Tzeng, I‐Tsu Chyuan · 2021 · Journal of the Formosan Medical Association
  18. Emerging biologic therapies for systemic lupus erythematosus
    Hiroshi Kato, Joanne Michelle Kahlenberg · 2024 · Current Opinion in Rheumatology
  19. Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus
    Warren David Raymond, Matthew Hamdorf, Michael Furfaro, Gro Østli Eilertsen, Johannes Cornelis Nossent · 2021 · Lupus Science & Medicine
  20. Oxidized galectin-1 in SLE fails to bind the inhibitory receptor VSTM1 and increases reactive oxygen species levels in neutrophils
    Xu Jiang, Xinyue Xiao, Hao Li, Yiyi Gong, Min Wang, Huaxia Yang, Lidan Zhao, Ying Jiang, Yanping Wei, Chongchong Zhao et al. · 2023 · Cellular and Molecular Immunology
  21. New therapeutics in systemic lupus erythematosus
    Ziv Paz, George C. Tsokos · 2013 · Current Opinion in Rheumatology
  22. The interaction between environmental triggers and epigenetics in autoimmunity
    Bruce Richardson · 2018 · Clinical Immunology
  23. Contribution of poly(ADP-ribose)polymerase-1 activation and apoptosis in trichloroethene-mediated autoimmunity
    Gangduo Wang, Huaxian Ma, Jianling Wang, M. Firoze Khan · 2018 · Toxicology and Applied Pharmacology
  24. Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases
    Ming Li, Wenjuan Gao, Jingjing Ma, Yun Zhu, Xingfu Li · 2015 · Experimental and Therapeutic Medicine
  25. Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients
    Marlena Kwiatkowska, Urszula Ołdakowska‐Jedynak, Ewa Wojtaszek, Tomasz Głogowski, Jolanta Małyszko · 2021 · Oxidative Medicine and Cellular Longevity
  26. Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus
    Xiangyu Teng, Josephine Brown, Laurence M Morel · 2021 · Antioxidants and Redox Signaling
  27. Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus
    Ryo Hisada, Nobuya Yoshida, Seo Yeon K. Orite, Masataka Umeda, Catalina Burbano, Marc Scherlinger, Michihito Kono, Suzanne Krishfield, George C. Tsokos · 2022 · Arthritis & Rheumatology
  28. Functional consequence of Iron dyshomeostasis and ferroptosis in systemic lupus erythematosus and lupus nephritis
    Laurence M Morel, Yogesh M. Scindia · 2024 · Clinical Immunology
  29. Upcoming therapeutic targets in cutaneous lupus erythematous
    Anna Sophie Klaeschen, Joerg Wenzel · 2016 · Expert Review of Clinical Pharmacology
  30. Biochemistry of Nitric Oxide and Peroxynitrite: Sources, Targets and Biological Implications
    Adrián Aicardo, Débora Martins Martinez, Nicolás Campolo, Silvina Bartesaghi, Rafael Radí · 2016 · Springer eBooks
  31. Oxidative stress and dietary micronutrient deficiencies contribute to overexpression of epigenetically regulated genes by lupus T cells
    Donna Ray, Faith M. Strickland, Bruce C. Richardson · 2018 · Clinical Immunology
  32. Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases
    Yuchen Zhao, Tianhao Xu, Zhenzhen Wu, Ning Li, Qianqian Liang · 2025 · Autoimmunity Reviews
  33. Molecular and therapeutic landscape of ferroptosis in skin diseases
    Jiayuan Le, Yu Meng, Ying Wang, Daishi Li, Furong Zeng, Yixiao Xiong, Xiang Chen, Guangtong Deng · 2024 · Chinese Medical Journal
  34. Functional Nanoparticles with a Reducible Tetrasulfide Motif to Upregulate mRNA Translation and Enhance Transfection in Hard‐to‐Transfect Cells
    Yue Wang, Jie Tang, Yannan Yang, Hao Song, Jianye Fu, Zhengying Gu, Chengzhong Yu · 2019 · Angewandte Chemie
  35. Editorial: Mitochondrial dysfunction in inflammation and autoimmunity
    Jens Staal, Luz P. Blanco, András Perl · 2023 · Frontiers in Immunology
  36. Inhibition of PAD4 mediated neutrophil extracellular traps prevents fibrotic osseointegration failure in a tibial implant murine model
    Emile-Victor Kuyl, Fei Shu, Branden R. Sosa, Juan D Lopez, Di Qin, Tania Pannellini, Lionel B. Ivashkiv, Matthew Blake Greenblatt, Mathias P. Bostrom, Xu Yang · 2021 · The Bone & Joint Journal
  37. Pharmacologic inhibition of glycolysis prevents the development of lupus by altering the gut microbiome in mice
    Ahmed Samir Elshikha, Yong Ge, Josephine Brown, Nathalie Kanda, Mojgan Zadeh, Georges Abboud, Seung‐Chul Choi, Gregg J. Silverman, Timothy J. Garrett, William L. Clapp et al. · 2023 · iScience
  38. Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy
    Scott B. Minchenberg, Geeta Chaparala, Zachary Oaks, Katalin Bánki, András Perl · 2018 · Clinical Immunology
  39. Immunophenotyping reveals distinct subgroups of lupus patients based on their activated T cell subsets
    Daniel J. Perry, Anton A. Titov, Eric S. Sobel, Todd M. Brusko, Laurence M Morel · 2020 · Clinical Immunology
  40. NETs: a new target for autoimmune disease
    Ran Tang, Jiahua Yin, Zhifang Qin, Min Zhang, Xiaoyi Jia · 2025 · Frontiers in Immunology
  41. Neutrophil-mediated Thrombosis and NETosis in Behçet's Disease: a Hypothesis
    Ezgi Deniz Batu · 2020 · Journal of Korean Medical Science
  42. Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review
    Karen Pesqueda-Cendejas, Melissa Rivera-Escoto, Mónica R. Meza-Meza, Bertha Campos-López, Isela Parra‐Rojas, Margarita Montoya‐Buelna, Ulises De la Cruz-Mosso · 2023 · Nutrients
  43. Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions
    Mohamed Jamal Saadh, Khadijehsadat Kazemi, Hossein Khorramdelazad, Mohammad Javad Mousavi, Negar Noroozi, Maryam Masoumi, Jafar Karami · 2023 · International Immunopharmacology
  44. Increasing glutathione levels by a novel posttranslational mechanism inhibits neuronal hyperexcitability
    Ashwini Sri Hari, Rajeswari Banerji, Liping Liang, Ruth E. Fulton, Christopher Quoc Huynh, Timothy Fabisiak, Pallavi Bhuyan McElroy, James R. Roede, Manisha Patel · 2023 · Redox Biology
  45. Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus
    Maria Teresa De Angelis, Gianluca Santamaria, Elvira Immacolata Parrotta, Stefania Scalise, Michela Lo Conte, Sara Gasparini, Edoardo Ferlazzo, Umberto Aguglia, Clara Ciampi, Antonella Sgura et al. · 2019 · Journal of Cellular and Molecular Medicine
  46. Protective effect of N-acetyl cysteine on the mitochondrial dynamic imbalance in temporal lobe epilepsy: Possible role of mTOR
    Ekram Mohammadi, Farnaz Nikbakht, Mahmood Barati, Mehrdad Roghani, Somayeh Vazifekhah, Ali Mohammadkhanizadeh, Zahra Heidari · 2022 · Neuropeptides
  47. Activated Lymphocyte-Derived DNA Drives Glucose Metabolic Adaptation for Inducing Macrophage Inflammatory Response in Systemic Lupus Erythematosus
    Han-Qing Zhao, Zhenke Wen, Sidong Xiong · 2023 · Cells
  48. Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus
    Shumei Cao, Jiao Jiang, Haoyuan Yin, Lai Wang, Qianjin Lu · 2024 · International Immunopharmacology
  49. Association of Oxidative Stress with Disease Activity and Damage in Systemic Lupus Erythematosus: A Cross Sectional Study from a Tertiary Care Centre in Southern India
    S Shruthi, Molly Mary Thabah, Zachariah Bobby, Vir Singh Negi · 2020 · Indian Journal of Clinical Biochemistry
  50. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease
    Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana Sathe, Jyothsna Gattineni, Tracey Wright, Christian Wysocki, M. Teresa de la Morena et al. · 2022 · Journal of Clinical Investigation
  51. Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes
    Line Kjær Winberg, Søren Jacobsen, Claus Henrik Nielsen · 2017 · Arthritis Research & Therapy
  52. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus
    Nayra Merino de Paz, María García-González, Fuensanta Gómez-Bernal, Juan Carlos Quevedo-Abeledo, Antonia de Vera-González, Raquel López‐Mejías, Pedro Abreu-González, Candelaria Martín‐González, Miguel Ángel González-Gay, Iván Ferraz‐Amaro · 2023 · Antioxidants
  53. The role of NETosis in the pathogenesis of immunoinflammatory rheumatic diseases
    Evgeny Lvovich Nasonov, Anastasia Sergeevna Avdeeva, Tatiana Magomedalievna Reshetnyak, Andrey P. Aleksankin, Yury P. Rubtsov · 2023 · Rheumatology Science and Practice
  54. Mitochondrial aberrations in systemic lupus erythematosus pathogenesis: Insights and therapeutic implications
    Haoguang Li, Lu Zhou, Wei Zhou, Xiuling Zhang, Jingjing Shang, Xueqin Feng, Le Yu, Jie Fan, Jie Ren, Rongwei Zhang et al. · 2024 · Rheumatology & autoimmunity
  55. Gluconolactone restores immune regulation and alleviates skin inflammation in lupus-prone mice and in patients with cutaneous lupus
    Wei Li, Antonios G.A. Kolios, Wenliang Pan, Catalina Burbano, Kohei Karino, Theodoros Vichos, Morgane Humbel, Vasileios C. Kyttaris, Maria Tsokos, George C. Tsokos · 2025 · The Journal of Immunology
  56. Nitrosative Stress and Nitrated Proteins in Trichloroethene-Mediated Autoimmunity
    Gangduo Wang, Jianling Wang, Xuemei Luo, G.A.S. Ansari, M. Firoze Khan · 2014 · PLoS ONE
  57. Altered Germinal-Center Metabolism in B Cells in Autoimmunity
    Ashton K. Shiraz, Eric James Panther, Christopher M. Reilly · 2022 · Metabolites
  58. Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4+ T Cells—Implications for the Pathogenesis of Systemic Lupus Erythematosus
    Joy S. Park, András Perl · 2023 · International Journal of Molecular Sciences
  59. Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
    Bayram Farisoğulları, Eduardo José Ferreira Santos, Emma K. Dures, Rinie Geenen, Pedro Machado · 2023 · RMD Open
  60. Metabolic Plasticity of Regulatory T Cells in Health and Autoimmunity
    Fortunata Carbone, Alessandra Colamatteo, Claudia La Rocca, Maria Teresa Lepore, Claudia Russo, Giusy De Rosa, Alessandro Matarese, Claudio Procaccini, Giuseppe Matarese · 2024 · The Journal of Immunology
  61. Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's disease
    André Gustavo Sampaio Costa, Nunes DPF, Paulo Rogério Júlio, Rodrigo Marchi-Silva, Bárbara Martins de Aquino, Samuel de Oliveira Andrade, Danilo Rodrigues Pereira, Taís Nitsch Mazzola, Jean Marcos de Souza, Alberto Rolim Muro Martinez et al. · 2025 · Autoimmunity Reviews
  62. Overview of Oxidative Stress in Systemic Lupus Erythematosus
    Ancuța Lupu, Gabriela Stoleriu, Alin Horațiu Nedelcu, Sara Nadeea Perju, Cristina Gavrilovici, Ginel Baciu, Cristina Maria Mihai, Tatiana Chisnoiu, Ionela Daniela Morariu, Ecaterina Grigore et al. · 2025 · Antioxidants
  63. Principles behind SLE treatment with N-acetylcysteine
    Sandy Nasr, András Perl · 2022 · Immunometabolism
  64. Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19
    Yénifer Gamarra-Morales, Lourdes Herrera‐Quintana, Jorge Molina‐López, Héctor Vázquez‐Lorente, Juan Francisco Machado-Casas, José Castaño-Pérez, J.M. Pérez-Villares, Elena Planells · 2023 · Nutrients
  65. Experiences and unmet needs of persons living with systemic lupus erythematosus in Europe: Lupus Europe's 2024 Swiss knife survey
    Alain Cornet, Z. Karakikla-Mitsakou, Jeanette Andersen, Sarah Dyball, R. Chotai, Annemarie Sluijmers, C. Sieiro Santos, Aldevina Sturiene, Lucy Scarle, Daniel Guimarães de Oliveira et al. · 2025 · Autoimmunity Reviews
  66. Neutrophil Extracellular Traps in Systemic Lupus Erythematosus: Pathogenic Mechanisms, Crosstalk with Oxidative Stress, and Antioxidant Therapeutic Potential
    Xi Chen, Danni Gao, M.-X. Wang, Lisheng Wang, Chengping Wen, Honghua Hu, Yujun Tang · 2025 · Antioxidants
  67. New and emerging therapies for systemic lupus erythematosus
    Eleni Papachristodoulou, Vasileios C. Kyttaris · 2024 · Clinical Immunology
  68. New Trials in Lupus and where Are we Going
    Aikaterini Thanou, Joan T. Merrill · 2018 · Current Rheumatology Reports
  69. Animal models of systemic lupus erythematosus and their applications in drug discovery
    Yue Xin, Bo Zhang, Junpeng Zhao, Qianmei Liu, Haoyuan Yin, Qianjin Lu · 2022 · Expert Opinion on Drug Discovery
  70. Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
    Jingquan He, Chiyu Ma, Donge Tang, Shaoyun Zhong, Xiaofang Yuan, Fengping Zheng, Zhipeng Zeng, Yumei Chen, Dongzhou Jeffrey Liu, Xiaoping Hong et al. · 2022 · Frontiers in Immunology
  71. Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus Erythematosus
    Gangduo Wang, Silvia S. Pierangeli, Rohan Willis, Emilio B. González, Michelle Petri, M. Firoze Khan · 2016 · PLoS ONE
  72. mTOR-dependent autophagy contributes to end-organ resistance and serves as target for treatment in autoimmune disease
    András Perl · 2018 · EBioMedicine
  73. Intersection of immune signaling and cell death: The bidirectional regulatory mechanism of STING pathway and Ferroptosis
    Yuxuan Yao, He Jax Xu, Yidan Zhu, Yiru Gong, Xuchen Song, Jiali Chen, Nan Guo, Yinyu Zhao, Jing Guo, Xingxian Luo et al. · 2025 · Autoimmunity Reviews
  74. Potential therapies targeting metabolic pathways in systemic lupus erythematosus
    Ryo Hisada, Michihito Kono · 2024 · Clinical Immunology
  75. Challenges and opportunities in SLE clinical trials
    Ronald van Vollenhoven · 2013 · Current Opinion in Rheumatology
  76. mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus
    Fabio Gelsomino, Andrea Casadei Gardini, Francesco Caputo, Giulio Rossi, Federica Bertolini, Tiziana Petrachi, Andrea Spallanzani, Elisa Pettorelli, Shaniko Kaleci, Gabriele Luppi · 2020 · Cancers
  77. The Pathophysiological Role of Mitochondrial Oxidative Stress in Rheumatic Diseases
    Zhao Ma, Qiaoping Xu, Xinchang Xu · 2025 · Journal of Inflammation Research
  78. Redox homeostasis, T cells and kidney diseases: three faces in the dark
    Luca Simeoni, Christoph Thurm, Andreas Kritikos, Andreas Linkermann · 2015 · Clinical Kidney Journal
  79. T cell metabolism and possible therapeutic targets in systemic lupus erythematosus: a narrative review
    Marcela Muñoz-Urbano, Diana Carolina Quintero-González, Gloria M Vásquez · 2022 · Immunopharmacology and Immunotoxicology
  80. Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry
    Katherine A. Owen, Kristy Bell, Andrew Price, Prathyusha Bachali, Hannah C. Ainsworth, Miranda C. Marion, Timothy D. Howard, Carl D. Langefeld, Nan Shen, Jinoos Yazdany et al. · 2023 · Scientific Reports
  81. Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis
    Yurilú Andreina González-Moret, Kevin Bryan Lo, Irene J Tan · 2024 · ACR Open Rheumatology
  82. Regulating T Cell Population Alleviates SLE by Inhibiting mTORC1/C2 in MRL/lpr Mice
    Dongya Zhang, Meiling Wang, Guo‐Ping Shi, Peng Pan, Jianjian Ji, Pengfei Li · 2021 · Frontiers in Pharmacology
  83. IL-21, Inflammatory Cytokines and Hyperpolarized CD8+ T Cells Are Central Players in Lupus Immune Pathology
    Soumya Sengupta, Gargee Bhattacharya, Subhasmita Mohanty, Shubham K. Shaw, Gajendra M. Jogdand, Rohila Jha, Prakash K. Barik, Jyoti Ranjan Parida, Satish Devadas · 2023 · Antioxidants
  84. Oxidative Stress as a Regulatory Checkpoint in the Production of Antiphospholipid Autoantibodies: The Protective Role of NRF2 Pathway
    Maurizio Sorice, Elisabetta Profumo, Antonella Capozzi, Serena Recalchi, Gloria Riitano, Benedetta Di Veroli, Luciano Saso, Brigitta Buttari · 2023 · Biomolecules
  85. N-Acetyl-l-Cysteine Supplement in Early Life or Adulthood Reduces Progression of Diabetes in Nonobese Diabetic Mice
    Lital Argaev-Frenkel, Hava Rozenfeld, Konstantin Rozenberg, Sanford R. Sampson, Tovit Rosenzweig · 2018 · Current Developments in Nutrition
  86. Ruxolitinib treatment reduces monocytic superoxide radical formation without affecting hydrogen peroxide formation or systemic oxidative nucleoside damage in myelofibrosis
    Mads Emil Bjørn, Marie Klinge Brimnes, Sif Gudbrandsdottir, Christen Lykkegaard Andersen, Henrik Enghusen Poulsen, Trine Henriksen, Hans Carl Hasselbalch, Claus Henrik Nielsen · 2019 · Leukemia & lymphoma/Leukemia and lymphoma
  87. Endosome traffic in rheumatic diseases: mechanistic insights and therapeutic opportunities
    András Perl · 2025 · Nature Reviews Rheumatology
  88. mTORC2 contributes to systemic autoimmunity
    Xian Zhou, Haiyu Qi, Meilu Li, Yanfeng Li, Xingxing Zhu, Shreyasee Amin, Mariam P. Alexander, Catherine M.M. Diadhiou, Anne Davidson, Hu Zeng · 2022 · Immunology
  89. Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity
    Akshay Patel, András Perl · 2021 · Antioxidants and Redox Signaling
  90. Aryl hydrocarbon receptor engagement during redox alteration determines the fate of CD4+ T cells in C57BL/6 mice
    Hamidreza Mohammadi, Gholamreza Daryabor, Ali Ghaffarian‐Bahraman, Majid Keshavarzi, Kurosh Kalantar, Afshin Mohammadi‐Bardbori · 2021 · Journal of Biochemical and Molecular Toxicology
  91. Exploring the ROS reduction strategies in chronic lupus management
    Kannika Parameshwari Kannan, A. S. Smiline Girija · 2024 · Frontiers in Immunology
  92. Anti-PS IgG Immune Complexes Impair Macrophage Phagocytosis in SLE via LOX-Dependent Oxidative Stress
    Hui Guan, Liqi Huang, Yu Liu, Enyi Zhu, Le‐Feng Chen, Weijie Li, Haiqi Wu, Xiaoying Zhang, Rencai Qin, Jingpeng Zheng et al. · 2025 · Journal of Inflammation Research
  93. T-cell-directed therapies in systemic lupus erythematosus
    Preeya Nandkumar, Richard Alan Furie · 2016 · Lupus
  94. Identification of polo‐like kinase 1 as a therapeutic target in murine lupus
    Yaxi Li, Hongting Wang, Zijing Zhang, Chenling Tang, Xinjin Zhou, Chandra Mohan, Tianfu Wu · 2022 · Clinical & Translational Immunology
  95. Changes in cardiorespiratory function and fatigue following 12 weeks of exercise training in women with systemic lupus erythematosus: a pilot study
    Sarfaraz Hasni, Li Feng, Marquis Chapman, Sarthak Gupta, Anam Ahmad, Adam Munday, Mir Mazhar, Xiaobai Li, Shajia Lu, Wanxia Li Tsai et al. · 2022 · Lupus Science & Medicine
  96. Mitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus
    Haitao Wang, Rui Tang, Qinyu Pan, Qiuyan Yin, Jian Feng, Li Deng · 2024 · International Immunopharmacology
  97. Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development
    Milena Tocut, Yehuda Shoenfeld, Gisele Zandman‐Goddard · 2020 · Expert Opinion on Investigational Drugs
  98. New Insights Into Systemic Lupus Erythematosus Therapies
    Danielle H. Wang, Daniel J. Wallace · 2020 · JCR Journal of Clinical Rheumatology
  99. Systemic Lupus Erythematosus
    Bhavyata Parag, William Towers · 2017 · The American Pharmacists Association eBooks
  100. Advances in therapeutic targets-related study on systemic lupus erythematosus.
    Xin Wang, Qing Zhang, Shuaihantian Luo, Huilin Zhang, Qianjin Lu, Hai Long · 2021 · PubMed Central